Back to top
more

Axon Enterprise (AXON)

(Delayed Data from NSDQ)

$613.26 USD

613.26
549,710

+15.67 (2.62%)

Updated Aug 25, 2026 04:00 PM ET

After-Market: $613.09 -0.17 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 14% (35 out of 246)

Industry: Aerospace - Defense Equipment

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Axovant (AXON) Gains on Licensing Deal with Oxford BioMedica

by Zacks Equity Research

Axovant Sciences' (AXON) shares rally, following news of a licensing deal for AXO-LentiPD from Oxford BioMedica for Parkinson's disease.

    Zacks Equity Research

    Options Traders Expect Huge Moves in Axovant Sciences (AXON) Stock

    by Zacks Equity Research

    Surging implied volatility makes Axovant Sciences (AXON) stock lucrative to the option traders.

      Zacks Equity Research

      Implied Volatility Surging for Axovant Sciences (AXON) Stock Options

      by Zacks Equity Research

      Surging implied volatility makes Axovant Sciences (AXON) stock lucrative to the option traders.

        Zacks Equity Research

        Are Options Traders Betting on a Big Move in Axovant Sciences (AXON) Stock?

        by Zacks Equity Research

        Surging implied volatility makes Axovant Sciences (AXON) stock lucrative to the option traders.

          Zacks Equity Research

          Keryx Biopharmaceuticals (KERX) in Focus: Stock Moves 10.8% Higher

          by Zacks Equity Research

          Keryx Biopharmaceuticals (KERX) was a big mover last session, as the company saw its shares nearly 11% on the day amid huge volumes.

            Zacks Equity Research

            Exact Sciences (EXAS) Looks Good: Stock Adds 9.8% in Session

            by Zacks Equity Research

            Exact Sciences (EXAS) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

              Zacks Equity Research

              Geron (GERN) in Focus: Stock Moves 9.2% Higher

              by Zacks Equity Research

              Geron (GERN) saw its shares rise over 9% on the day after the company received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its experimental blood-cancer medicine, imetelstat.

                Zacks Equity Research

                Alkermes (ALKS) in Focus: Stock Moves 11.1% Higher

                by Zacks Equity Research

                Alkermes plc (ALKS) saw its shares rise over 11% on the day.

                  Zacks Equity Research

                  Envision Healthcare (EVHC) Looks Good: Stock Adds 10.9% in Session

                  by Zacks Equity Research

                  Envision Healthcare (EVHC) was a big mover last session, as the company saw its shares rise almost 11% on the day amid huge volumes.

                    Zacks Equity Research

                    Abeona Therapeutics (ABEO) Surges: Stock Moves 7.2% Higher

                    by Zacks Equity Research

                    Abeona Therapeutics (ABEO) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.